Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Gudin

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Pain & Palliative Care Pharmacotherapy|July 7, 2012
Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practiceJeffrey Gudin
Journal of Pain and Symptom Management|December 11, 2012
Opioid therapies and cytochrome p450 interactionsJeffrey Gudin
Journal of Opioid Management|April 25, 2020
Effect of physical manipulation on the oral pharmacokinetic profile of Xtampza<sup>®</sup> ER (oxycodone DETERx<sup>®</sup> formulation): A review of published studiesJeffrey Gudin
Journal of Pain Research|October 16, 2020
Characteristics of Analgesic Patch FormulationsSrinivas Nalamachu, Jeffrey Gudin
Journal of Pain Research|June 10, 2024
Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to AccessLynn Webster, Jeffrey Gudin
Journal of Pain Research|March 12, 2020
Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug InteractionsJeffrey Gudin, Jeffrey Fudin
Pain and Therapy|January 30, 2020
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic PainJeffrey Gudin, Jeffrey Fudin
Journal of Family Medicine and Primary Care|October 3, 2025
Decreased anxiety through haptic technology patch usage: A case-control comparisonJanet Fason, Jeffrey Gudin, Peter Hurwitz
Pain and Therapy|October 7, 2025
Reducing Pain and Improving Mobility Using Haptic Patch Technology: Results of the RESTORE StudyJanet Fason, Peter Hurwitz, Jeffrey Gudin
Postgraduate Medicine|December 5, 2015
Levorphanol use: past, present and futureJeffrey Gudin, Jeffrey Fudin, Srinivas Nalamachu
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Pain & Palliative Care Pharmacotherapy|July 7, 2012
Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practiceJeffrey Gudin
Journal of Pain and Symptom Management|December 11, 2012
Opioid therapies and cytochrome p450 interactionsJeffrey Gudin
Journal of Opioid Management|April 25, 2020
Effect of physical manipulation on the oral pharmacokinetic profile of Xtampza<sup>®</sup> ER (oxycodone DETERx<sup>®</sup> formulation): A review of published studiesJeffrey Gudin
Journal of Pain Research|October 16, 2020
Characteristics of Analgesic Patch FormulationsSrinivas Nalamachu, Jeffrey Gudin
Journal of Pain Research|June 10, 2024
Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to AccessLynn Webster, Jeffrey Gudin
Journal of Pain Research|March 12, 2020
Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug InteractionsJeffrey Gudin, Jeffrey Fudin
Pain and Therapy|January 30, 2020
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic PainJeffrey Gudin, Jeffrey Fudin
Journal of Family Medicine and Primary Care|October 3, 2025
Decreased anxiety through haptic technology patch usage: A case-control comparisonJanet Fason, Jeffrey Gudin, Peter Hurwitz
Pain and Therapy|October 7, 2025
Reducing Pain and Improving Mobility Using Haptic Patch Technology: Results of the RESTORE StudyJanet Fason, Peter Hurwitz, Jeffrey Gudin
Postgraduate Medicine|December 5, 2015
Levorphanol use: past, present and futureJeffrey Gudin, Jeffrey Fudin, Srinivas Nalamachu
Pageof 4